The Hidden Cost Driver: Why Blood Pressure Should Be Your Top Benefits Priority

Hypertension is one of the leading causes of cardiovascular (heart attack), neurovascular (stroke), and chronic kidney disease. It is also one of the largest contributors to inpatient utilization and total medical plan cost for most self-insured employers. The challenge is that hypertension is treatable, which means a significant amount of inpatient utilization and health plan cost is preventable, yet it causes few, if any, early symptoms. Benefits leaders must move beyond education alone, as engagement with home monitoring remains inconsistent even when devices, education, and support are provided (Unlu et al., 2026). They must instead create financial alignment and tangible value.

First, educate employees not only on health benefits but also on the financial rewards, showing how reduced medical spend can translate into improved compensation. Second, tier health plan benefits to remove barriers and reward PROACTIVE CARE, such as primary care screening and treatment. Third, offer free and convenient on-site screenings and navigation services quarterly to reinforce urgency and organizational investment. Fourth, track and communicate progress semiannually, showing how engagement reduces hospitalization risk and protects paychecks.

These actions are critical, especially as reducing sodium intake from processed foods alone has been shown to lower blood pressure and prevent substantial numbers of heart disease cases, strokes, and deaths (Grave et al., 2026; Bandy et al., 2026). We talk often about generating engagement, yet many strategies fail because they lack tangible value. A better approach is to create financial alignment first. Make the abstract goal of controlling a hidden, painless disease more tangible, obtainable, and exciting today. Employers looking to slow the year-over-year increase in total cost of care should focus their population on blood pressure. The clinical, financial, and human returns are too significant to ignore.

Unlu, O., Zelle, D., Cannon, C. P., et al. (2026). Patient engagement with home blood pressure monitoring. JAMA Cardiology. Advance online publication. https://doi.org/10.1001/jamacardio.2025.5196

Grave, C., Carcaillon-Bentata, L., Bonaldi, C., Blacher, J., & Olié, V. (2026). From French gastronomy to cardiovascular health: Cutting salt in the baguette has saved thousands of lives in France. Hypertension. https://doi.org/10.1161/HYPERTENSIONAHA.125.25977

Bandy, L., Amies-Cull, B., Luick, M., Cobiac, L. J., Jebb, S. A., & Scarborough, P. (2026). Estimating the potential impact of the 2024 UK salt reduction targets on cardiovascular health outcomes and health care costs in adults: A modeling study. Hypertension. https://doi.org/10.1161/HYPERTENSIONAHA.125.25159